Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Low Dose Pioglitazone to Treat Autosomal Dominant Polycystic Kidney

NCT02697617 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.

NCT NCT02697617
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02697617 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Low Dose Pioglitazone to Treat Autosomal Dominant Polycystic Kidney
Lead sponsor
Indiana University
Phase
Phase 2
Overall status
Completed
Start date
January 26, 2016
Completion date
January 31, 2020
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

polycystic kidney disease